T5
Last reporting period 30 Jun, 2021
Updated 19 Sep, 2024
Last price
—
Market cap $B
0
Exchange
XETR - Xetra
0.022 B
Last period Assets ,EUR
106%
Assets has increased in 5 years
What is Assets ?
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
See also bioXXmed
Company Analysis
T5O.DE valuation, rating, competitors, insights and company profile
Eyestock Rating
T5O.DE financial analysis by Eyestock methodology
Valuation
T5O.DE valuation using historical relative method
Statements
T5O.DE Income Statements, Balance Sheet and Cash Flow Statements
Dividends
T5O.DE dividend yield and annual dividend
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
bioXXmed`s Assets for the period ended 2021-06-30 are 0.022 B EUR
